Utilize este identificador para referenciar este registo:
https://hdl.handle.net/1822/65650
Registo completo
Campo DC | Valor | Idioma |
---|---|---|
dc.contributor.author | Campos, Joana R. | por |
dc.contributor.author | Fernandes, Ana R. | por |
dc.contributor.author | Sousa, Raquel | por |
dc.contributor.author | Fangueiro, Joana F. | por |
dc.contributor.author | Boonme, Prapaporn | por |
dc.contributor.author | Garcia, Maria Luisa | por |
dc.contributor.author | Silva, Amelia M. | por |
dc.contributor.author | Naveros, Beatriz C. | por |
dc.contributor.author | Souto, Eliana B. | por |
dc.date.accessioned | 2020-06-17T14:03:12Z | - |
dc.date.available | 2020-06-17T14:03:12Z | - |
dc.date.issued | 2019-05 | - |
dc.identifier.citation | Campos, Joana R.; Fernandes, Ana R.; Sousa, Raquel; Fangueiro, Joana F.; Boonme, Prapaporn; Garcia, Maria Luisa; Silva, Amelia M.; Naveros, Beatriz C.; Souto, Eliana, Optimization of nimesulide-loaded solid lipid nanoparticles (SLN) by factorial design, release profile and cytotoxicity in human Colon adenocarcinoma cell line. Pharmaceutical Development and Technology, 24(5), 616-622, 2019 | por |
dc.identifier.issn | 1083-7450 | por |
dc.identifier.uri | https://hdl.handle.net/1822/65650 | - |
dc.description.abstract | The aim of this work is development of a nontoxic, long-term stable solid lipid nanoparticles (SLN) formulation for the loading of Nimesulide (NiM) by a 22 factorial design. The optimized formulation was composed of 10wt% of glyceryl behenate and 2.5wt% of poloxamer 188. Immediately after production, Z-Ave of NiM-SLN was 166.1±0.114nm, with a polydispersity index (PI) of 0.171±0051 and zeta potential nearly neutral (3.10±0.166mV). A slight increase of Z-Ave was recorded for NiM-SLN stored at 25°C for a period of 15days, whereas at 4°C particles kept size within similar range. Long-term stability was monitored using TurbiscanLab®, showing a high stability of the nanoparticles with variations in the backscattering profiles below 10%. The release profile of NiM-SLN followed a sustained pattern with ca. 30% of drug released up to 24h. Empty-SLN and NiM-SLN were nontoxic after exposing Caco-2 cells to the highest concentration (100g/mL) up to 48hours (cell viability higher than 80%). NiM-SLN were lyophilized using different cryoprotectants, producing particles of 463.1±36.63nm (PI 0.491±0.027) with 5% trehalose. Solid character of NiM-SLN was confirmed by DSC, recording a recrystallization index of 83% for NiM-SLN and of 74% for lyophilized SLN. | por |
dc.description.sponsorship | This work was financed through the projects M-ERA-NET/0004/2015-PAIRED, receiving financial support from the Portuguese Science and Technology Foundation, Ministry of Science and Education (FCT/MEC) through national funds, and co-financed by FEDER, under the Partnership Agreement PT2020. This work was also supported by the Spanish Ministry of Science and Innovation (MAT 2014-59134-R projects; 2014SGR-1023). | por |
dc.language.iso | eng | por |
dc.publisher | Marcel Dekker Inc. | por |
dc.rights | openAccess | por |
dc.subject | Nimesulide | por |
dc.subject | solid lipid nanoparticles | por |
dc.subject | physical stability | por |
dc.subject | factorial design experiment | por |
dc.subject | lyophilization | por |
dc.subject | trehalose | por |
dc.subject | cryoprotectants | por |
dc.title | Optimization of nimesulide-loaded solid lipid nanoparticles (SLN) by factorial design, release profile and cytotoxicity in human Colon adenocarcinoma cell line | por |
dc.type | article | - |
dc.peerreviewed | yes | por |
dc.relation.publisherversion | https://www.tandfonline.com/loi/iphd20 | por |
dc.comments | CEB49486 | por |
oaire.citationStartPage | 616 | por |
oaire.citationEndPage | 622 | por |
oaire.citationIssue | 5 | por |
oaire.citationVolume | 24 | por |
dc.date.updated | 2020-04-12T12:04:40Z | - |
dc.identifier.eissn | 1097-9867 | por |
dc.identifier.doi | 10.1080/10837450.2018.1549075 | por |
dc.identifier.pmid | 30477410 | por |
dc.description.publicationversion | info:eu-repo/semantics/publishedVersion | - |
dc.subject.wos | Science & Technology | por |
sdum.journal | Pharmaceutical Development and Technology | por |
Aparece nas coleções: | CEB - Publicações em Revistas/Séries Internacionais / Publications in International Journals/Series |
Ficheiros deste registo:
Ficheiro | Descrição | Tamanho | Formato | |
---|---|---|---|---|
document_49486_1.pdf | 563,34 kB | Adobe PDF | Ver/Abrir |